reSee.it - Related Video Feed

Dr. Albert Bourla, Pfizer's chairman and CEO, is recognized for his significant impact on global COVID-19 response efforts. As a child of Holocaust survivors, Bourla led his team to develop a COVID-19 vaccine in record time, declining US federal funding to avoid bureaucracy and accelerate production. He is proud of his Jewish heritage, active in Holocaust remembrance, and a strong supporter of Israel, which was the first country outside the US to receive the Pfizer vaccine and antiviral pill. With over 2.5 billion Pfizer vaccine doses distributed, Bourla is credited with helping to save lives during the pandemic. For his contributions, Dr. Bourla has been selected as the recipient of the 2022 Genesis Prize, also known as the "Jewish Nobel Prize."

Digital certificates are needed for people working in nursing homes, hospitals, and schools to authenticate their vaccination status. Travel may also require such authentication. Pfizer broke every record in developing the vaccine.

Israel was the first to emerge from COVID by using its advanced medical database to analyze the effects of Pfizer's vaccines on different health conditions. This database, covering 98% of the population, allowed for quick and efficient monitoring. Israel's collaboration with Pfizer turned the country into a testing ground, providing valuable data to the world.

The Prime Minister of Israel discusses the country's progress in vaccinating its population against COVID-19. Currently, 82% of people above 60 years old have been vaccinated, but the goal is to reach 95%. The challenge lies in the race between vaccination and mutation, particularly with the British mutation and potential future mutations. Israel aims to vaccinate the high-risk groups first and then the rest of the population. The Prime Minister expects vaccine companies to modify their vaccines to address new mutations. Israel's success in vaccination is attributed to quick and decisive action, including purchasing vaccines without hesitation and personal leadership involvement. The country's efficient distribution system, facilitated by four competing and cooperating HMOs, has allowed it to serve as a laboratory for achieving herd immunity.

In the fight against COVID-19, Pfizer CEO Dr. Albert Bourla, a child of Holocaust survivors, played a key role in developing the vaccine. His Jewish heritage and support for Israel are notable. Over 2.5 billion Pfizer vaccine doses have been distributed worldwide. For his contributions, Dr. Bourla received the 2022 Genesis Prize, known as the Jewish Nobel Prize. The pandemic continues, but Dr. Bourla's efforts have made a significant impact in saving lives globally.

Israel has vaccinated 82% of people over 16 and aims for 95%. The challenge is the race between vaccination and mutations. Israel's success is due to quick vaccine purchases and personal leadership. The country can serve as a global example for achieving herd immunity.

An Israeli intelligence company called First Health Infrastructure partnered with CISA, an organization responsible for protecting critical infrastructure in the US. Originally focused on American hospitals, they have expanded their services to include dams, water systems, and nuclear reactors. This foreign intelligence-founded nonprofit now has access to these crucial systems in the United States. The deep connections between Israel and the US seem to play a role in allowing this partnership.

Today, I'm announcing Genome UK, the UK's genomic strategy for the future of healthcare. The UK has been a leader in genomic research, from the discovery of DNA's double helix form to sequencing the first genome and the 100,000 Genome Project. Genomics has the potential to revolutionize healthcare by understanding genetic codes and medical conditions, leading to earlier diagnoses and prevention of illnesses like cancer. We aim to maintain British leadership in genomic science and support the brilliant scientists driving this project. We invite global participation in our research to improve global health and gain transformative insights for the 21st century.

In the video, the speaker talks about how Israel was able to come out of COVID first. They mention a book called "My Conversations With Albert Bourla of Pfizer" where they convinced him to give Israel the necessary vaccines. Israel's advantage was their extensive medical database, with 98% of the population having digitized medical records. This allowed them to analyze the vaccines' effects on different conditions, such as meningitis and high blood pressure, on a statistical level. Israel became a testing ground for Pfizer, and the information they gathered was shared with the world through medical publications.

In this video, the speaker discusses how Israel was able to come out of COVID first by using their extensive medical database. They persuaded Pfizer to provide vaccines by utilizing their 98% digitized medical records. Israel became a testing ground for Pfizer's vaccines, and the information was shared with the world. The speaker also mentions their plan to create a genetic database by collecting saliva samples from the population. They believe this database can be used by pharmaceutical and medical companies to develop groundbreaking technologies. The speaker emphasizes the potential benefits not only for Israel but also for their neighbors in the Middle East and the world.

We negotiated with Pfizer for a deal to efficiently vaccinate a large portion of the Israeli population. We assured Pfizer that we would not share personal data but would monitor the vaccine's impact on disease levels, economy, and social life. We will track any effects on specific groups, like those with heart conditions, while respecting privacy.

Speaker 0: My goal is to protect Israel and ensure its future. I want to be remembered as its protector. Speaker 1: Welcome, Mr. Prime Minister. Speaker 0: Thank you. Speaker 1: We convinced Pfizer that they could benefit from our data, and our health system distributed it efficiently through our digital system. I spoke with Pfizer's CEO 21 times, not 70. I also spoke with other company heads. Personal leadership is crucial in ensuring vaccine stock and distribution. Israel can serve as a global test case to understand the efficacy of vaccination in reopening economies. We are taking calculated risks to move forward and many countries can learn from us.

In the global fight against COVID-19, the Jewish people have had an outsized impact. As scientists, chief medical officers, and top healthcare officials, their contributions have been invaluable. However, one person stands above the rest: Pfizer Chairman and CEO, Dr. Albert Borla. I led my team to deliver a COVID-19 vaccine in record time, declining US federal funding to avoid bureaucracy and expedite production. As a child of Holocaust survivors, I am proud of my Jewish heritage and a strong supporter of Israel, the first country outside the US to receive the Pfizer vaccine and antiviral pill. The world is better off with my leadership in saving lives. With over 2.5 billion Pfizer vaccine doses distributed, I am honored to be selected as the recipient of the 2022 Genesis Prize, the Jewish Nobel Prize, for my contribution to humanity during the worst health crisis in a century.

The COVID-19 pandemic highlighted the importance of digital health solutions in providing access to healthcare. The European Union invested in COVID-19 certificates to facilitate safe movement during the pandemic. Now, the World Health Organization (WHO) is launching the global digital health certification network, building on the success of the EU system. WHO will start with the existing COVID-19 certificate and expand it to include other uses like vaccination records and patient summaries. They aim to make this network accessible worldwide and thank the European Union for their contribution.

We in the European Union are working to strengthen health systems and promote digitalization in healthcare globally. During the pandemic, we quickly implemented a digital COVID certificate to facilitate travel and revive economies. This initiative has been adopted by WHO and over 80 countries. We must think innovatively, move forward, and embrace the potential benefits of digital health while being mindful of the risks.

Israel was able to come out of COVID first by using its extensive medical database, which includes digitized medical records for 98% of the population. This allowed them to analyze the effects of vaccines on different medical conditions. Israel became a testing ground for Pfizer, and the information gathered was shared with the world. The plan now is to expand the database to include genetic records from the entire population, creating a powerful resource for medical and biotechnological advancements. Israel aims to prioritize Israeli firms initially, but ultimately hopes to benefit the Middle East and the world with groundbreaking technologies.

A proper digital infrastructure is critical for managing vaccinations, especially with multiple-shot vaccines. It's essential to track who has been vaccinated. This is important not only for healthcare in general, but specifically for managing pandemics and vaccine distribution. However, most countries currently lack this necessary digital infrastructure.

Speaker 0 emphasizes the importance of protecting the future of Israel and being remembered as its protector. They discuss their interactions with Pfizer and the digitized health system in Israel, which has 1400 distribution sites. Speaker 0 mentions speaking with Pfizer and Moderna representatives, highlighting the need for personal leadership in vaccine distribution. They stress the importance of acquiring and distributing vaccines efficiently. Speaker 0 concludes by stating that Israel can serve as a global test case.

The COVID-19 pandemic emphasized the importance of digital health solutions in providing access to healthcare services. The European Union's COVID-19 certificate system, used by all member states and over 50 other countries, was successful in facilitating safe movement during the pandemic. Building on this success, the World Health Organization (WHO) is launching the global digital health certification network. WHO expresses gratitude to the European Union for sharing their excellent certification system. The network will initially include the COVID-19 certificate and will later incorporate other documents like vaccination records and patient summaries. WHO will collaborate with all regions to ensure accessibility of the network.

Israel emerged from COVID-19 by leveraging its extensive medical database, which includes digitized records for 98% of the population. This allowed for effective collaboration with Pfizer to assess vaccine impacts on various health conditions. The data was shared globally, contributing to medical knowledge. Plans are in place to expand this database by incorporating genetic information through voluntary saliva samples, creating a robust resource for research. This diverse genetic and medical database will enable pharmaceutical and medical companies to develop innovative biotechnological solutions. Initially, Israeli firms will have priority access, fostering a groundbreaking industry that can benefit not only Israel but also neighboring countries and the world.

Israel is leading the medical revolution with bioconvergence technologies combining biology and engineering. Companies like Biomics and Nano Retina are creating innovative solutions for chronic diseases and vision impairment. PreciseBio is biofabricating tissues using 3D printing. Collaborating with ICT, big data, and AI, Israel is developing integrative medical solutions. The Israel Innovation Authority supports projects and partnerships, driving groundbreaking advancements in personalized medicine. With $40 billion in worldwide medicine profits from Israeli inventions, Israel's exceptional innovation ecosystem is a crucial player in shaping the future of healthcare.

We need to track who has been vaccinated and who hasn't, especially with upcoming vaccines that may require multiple shots. A robust digital infrastructure is crucial for healthcare in general and particularly during a pandemic. Unfortunately, many countries lack this infrastructure.

You need personal leadership to make a difference. Israel could be a global example for achieving herd immunity.

Having a strong digital infrastructure is crucial for effective healthcare, especially during a pandemic or vaccination efforts. It is important to have accurate data on who has been vaccinated and who hasn't, as future vaccines may require multiple shots. Unfortunately, most countries lack the necessary digital infrastructure for this purpose.

Israel was the first to emerge from COVID by using its advanced medical database to analyze the effects of vaccines on different health conditions. By partnering with Pfizer, Israel became a testing ground for vaccine efficacy. The data collected was shared globally through medical publications.